IOL Chemicals & Pharmaceuticals Limited has submitted newspaper publications to stock exchanges regarding the re-launch of the "Saksham Niveshak" campaign, following its earlier announcement of participation in this regulatory initiative. The company disclosed the newspaper advertisement submission on April 10, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Newspaper Publication Details

The company submitted copies of newspaper advertisements titled "Re-Launch of Second 100 Days Campaign 'Saksham Niveshak'" published across multiple languages to ensure wider reach among shareholders. The publications were strategically placed in prominent newspapers to maximize awareness.

Campaign Overview and Timeline

The Second 100-Day Campaign titled "Saksham Niveshak" has been launched by the Investor Education and Protection Fund Authority (IEPFA) under the Ministry of Corporate Affairs. IOL Chemicals is actively participating in this initiative to help shareholders claim unpaid dividends and update their KYC details.

Key Campaign Objectives

The campaign focuses on three primary objectives to benefit shareholders and ensure regulatory compliance. The company aims to facilitate direct settlement of unclaimed dividends, assist with KYC compliance updates, and prevent transfers to the Investor Education and Protection Fund.

Direct Settlement Process:

• Facilitating payment of unclaimed or unpaid dividends directly to rightful shareholders
• Streamlined process through Registrar and Share Transfer Agent
• Multiple communication channels for shareholder assistance

KYC Compliance Requirements:

• Updating bank account mandates and PAN details
• Registration of email ID and mobile number
• Address verification and nomination updates
• Compliance with applicable SEBI requirements

Shareholder Action Requirements

Shareholders are advised to take immediate action to update their details before the campaign deadline. The company has outlined specific procedures for different categories of shareholders to ensure smooth processing.

Physical Shareholders Process

Demat Shareholders Process

Shareholders holding shares in demat form must contact their Depository Participants (DP) directly for KYC updates. The company emphasizes that all dividend payments will be made only through electronic mode, and payments will be withheld for folios where required details have not been updated.

Contact Information:

• Registrar: Alankit Assignments Limited
• Address: 4E/2, Jhandewalan Extension, New Delhi-110055
• Phone: +91-11-4254 1234
• Email: rta@alankit.com

The company has made all necessary forms and unclaimed dividend details available on its website to facilitate shareholder participation in the campaign.

Source: Company/INE485C01029/74689239-466c-4db5-ad90-b4c22168ee09.pdf

IOL Chemicals & Pharmaceuticals Limited has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The filing, dated April 4, 2026, was communicated to both the National Stock Exchange of India Limited and BSE Limited through the company's registrar and share transfer agent.

Regulatory Compliance Filing

The certificate was issued by Alankit Assignments Limited, serving as the company's Registrar and Share Transfer Agent. The document confirms compliance with the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, specifically under Regulation 74(5) requirements.

Certificate Confirmation

Alankit Assignments Limited certified several key compliance points regarding the dematerialization process:

• Securities comprised in the certificates have been listed on stock exchanges
• Physical certificates received for dematerialization have been properly verified, mutilated, and cancelled
• The depository name has been substituted in records as the registered owner
• Required certificates were submitted to depositories and stock exchanges within specified time limits

Stock Exchange Communication

The compliance certificate was formally communicated to both major Indian stock exchanges where IOL Chemicals and Pharmaceuticals shares are traded. The company trades on NSE under the symbol IOLCP and on BSE under security code 524164.

Corporate Governance

The filing was signed by Abhay Raj Singh, Senior Vice President and Company Secretary of IOL Chemicals and Pharmaceuticals Limited. On behalf of the registrar, Kamal Garg, General Manager at Alankit Assignments Limited, digitally signed the compliance certificate.

This quarterly filing represents standard regulatory compliance for listed companies, ensuring proper documentation and transparency in the dematerialization process of physical share certificates during the quarter ended March 31, 2026.